PROPHET Trademark

Trademark Overview


On Monday, March 7, 2022, a trademark application was filed for PROPHET with the United States Patent and Trademark Office. The USPTO has given the PROPHET trademark a serial number of 97299949. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Saturday, January 27, 2024. This trademark is owned by CerFlux, Inc.. The PROPHET trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Data automation and collection service using proprietary software to evaluate, analyze and collect service data; Data conversion of computer program data or information, other than physical conversion; Data conversion of computer programs and data, not physical conversion; Data conversion of electronic information; Data decryption services; Data encryption and decoding services; Data encryption services; Data encryption services for providing security and anonymity for electronically transmitted credit card transactions; Data migration services; Data mining; Data security consultancy; Data warehousing; Data-acquisition and collection for calibration and coordinate-measurement purposes; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Advanced product research in the field of artificial intelligence; Application service provider (ASP) featuring software using artificial intelligence for biotechnology, pharmaceutical, oncology...
prophet

General Information


Serial Number97299949
Word MarkPROPHET
Filing DateMonday, March 7, 2022
Status645 - FINAL REFUSAL - MAILED
Status DateSaturday, January 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesData automation and collection service using proprietary software to evaluate, analyze and collect service data; Data conversion of computer program data or information, other than physical conversion; Data conversion of computer programs and data, not physical conversion; Data conversion of electronic information; Data decryption services; Data encryption and decoding services; Data encryption services; Data encryption services for providing security and anonymity for electronically transmitted credit card transactions; Data migration services; Data mining; Data security consultancy; Data warehousing; Data-acquisition and collection for calibration and coordinate-measurement purposes; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Advanced product research in the field of artificial intelligence; Application service provider (ASP) featuring software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Application service provider, namely, hosting, managing, developing, and maintaining applications, software, and web sites, in the fields of personal productivity, wireless communication, mobile information access, and remote data management for wireless delivery of content to handheld computers, laptops and mobile electronic devices; Authentication of data in the field of biotechnology, pharmaceutical, oncology, medical/health records using blockchain technology; Backup services for computer hard drive data; Cloud storage services for electronic data; Compiling data for research purposes in the field of medical science and medical consultancy; Computer compatibility services, namely, data mapping; Computer programming services for data processing; Computer security threat analysis for protecting data; Computer services in the nature of customized web pages and other data feed formats featuring user-defined information; Computer services, namely, data recovery services; Computer services, namely, encrypted data recovery services; Computer services, namely, on-line scanning, detecting, quarantining and eliminating of viruses, worms, trojans, spyware, adware, malware and unauthorized data and programs on computers and electronic devices; Computer services, namely, providing search engines for obtaining data on a global computer network; Computer services, namely, providing virtual and non virtual application servers, web servers, file servers, co-location servers, load balancing servers, redundancy servers, media servers and database servers of variable capacity to third party computing and data storage facilities; Conducting early evaluations in the field of new pharmaceuticals; Consultancy in the field of artificial intelligence technology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Conversion of data or documents from physical to electronic media; Conversion of computer programs and data, other than physical conversion; Design and development of computer software for biotechnology, pharmaceutical, oncology, medical/health records; Design and development of electronic data security systems; Design and development of integrated data collection and wireless transmission hardware systems for equipment and for software applications associated with that equipment at mining, construction, and industrial sites; Design and development of software and hardware for data and multimedia content conversion from and to different protocols; Design and development of software and hardware for multimedia data storing and recalling; Design and development of wireless communication systems for transmission and reception of voice, data and video; Design of information graphics and data visualization materials; Developing customized web pages and other data feed formats featuring user-defined information; Developing customized web pages and other data feed formats featuring user-defined information in the field of biotechnology, pharmaceutical, oncology, medical/health records; Development and creation of computer programmes for data processing; Development of pharmaceutical preparations and medicines; Development of computer programs recorded on data media (software) designed for use in construction and automated manufacturing (cad/cam); Digital compression of computer data; Digital compression of biotechnology, pharmaceutical, oncology, medical/health records data; Digital enhancement and manipulation of radiological data by means of computerized software for use in the field of biotechnology, pharmaceutical, oncology, medical/health services; Document data transfer from one computer format to another; Electronic data back-up services; Electronic data storage; Electronic monitoring and reporting of biotechnology, pharmaceutical, oncology, medical/health records data using computers or sensors; Electronic monitoring of biotechnology, pharmaceutical, oncology, medical/health records data using computers and sensors; Electronic storage of electronic media, namely, images, text and audio data; Electronic storage of biotechnology, pharmaceutical, oncology, medical/health records data; Electronic storage services for archiving databases, images and other electronic data; Electronic storage services for archiving electronic data; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research in the field of oncology; Medical research services in the field of cancer; Pharmaceutical products development; Pharmaceutical research and development; Providing a website featuring non-downloadable software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing information about medical research in the field of biotechnology, pharmaceutical, oncology, medical/health records; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Providing on-line non-downloadable software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing temporary use of online non-downloadable chatbot software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Rental of humanoid robots with artificial intelligence; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of artificial intelligence; Research in the field of artificial intelligence technology; Research on the subject of pharmaceuticals; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of biotechnology, pharmaceutical, oncology, medical/health records; Software as a service (SAAS) services featuring software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Technical consulting in the field of artificial intelligence (AI) software customization; Technical consulting in the field of pharmaceutical studies; Technical consulting in the field of monitoring technological functions of humanoid robots with artificial intelligence; Technical research in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 11, 2022
Primary Code042
First Use Anywhere DateMonday, November 1, 2021
First Use In Commerce DateMonday, November 1, 2021

Trademark Owner History


Party NameCerFlux, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35203

Trademark Events


Event DateEvent Description
Saturday, January 27, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, January 27, 2024FINAL REFUSAL E-MAILED
Saturday, January 27, 2024FINAL REFUSAL WRITTEN
Wednesday, January 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 2, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, January 2, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, January 2, 2024PETITION TO REVIVE-GRANTED
Tuesday, January 2, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, December 5, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, December 4, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, December 4, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 17, 2023NON-FINAL ACTION E-MAILED
Thursday, August 17, 2023NON-FINAL ACTION WRITTEN
Wednesday, July 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2023ASSIGNED TO LIE
Tuesday, March 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 3, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 3, 2023NON-FINAL ACTION WRITTEN
Friday, December 16, 2022ASSIGNED TO EXAMINER
Friday, March 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 10, 2022NEW APPLICATION ENTERED